Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

COVID19´Â ¼öÇ÷°ú Ç÷¾×°ü¸®¿¡ ¾î¶°ÇÑ ¿µÇâÀ» ¹ÌÄ¡´Â°¡? How Does COVID19 Affect Blood Transfusion and Blood Management?

´ëÇѼöÇ÷ÇÐȸÁö 2020³â 31±Ç 1È£ p.1 ~ 4
ÀÓ¿µ¾Ö, ¼­µ¿Èñ, ȲÀ¯¼º,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÓ¿µ¾Ö ( Lim Young-Ae ) 
Ajou University School of Medicine Department of Laboratory Medicine

¼­µ¿Èñ ( Seo Dong-Hee ) 
LabGenomics Clinical Laboratories
ȲÀ¯¼º ( Hwang Yoo-Sung ) 
Hanmaeum Blood Center

Abstract


The scientific interest in transfusion medicine as related to COVID19 can be summarized in three important points. 1) How can we identify asymptomatic COVID19 infected potential blood donors from healthy donors, and if the asymptomatic COVID19 infected person has donated blood and it has been transfused, how will it affect the transfused patient? 2) What affect will COVID19 have on blood establishments and medical institutions that use blood? 3) How will convalescent plasma from recovered COVID-19 patients be collected and then be used for patients in need of it? Since COVID19 has a negative effect on blood transfusion and blood management, well developed lines of communication and cooperation from blood establishments, medical institutions, government agencies, and people are urgently needed to overcome the impact of this negative effect.

Å°¿öµå

COVID 19; Blood; Transfusion

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS